The high-dose version of Regeneron’s eye treatment Eylea hit its primary endpoint in a late-stage study for macular edema following retinal vein occlusion, a common …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
On April 26, 2024, the Federal Trade Commission (FTC) issued a significant final rule amending its Health Breach Notification Rule (HBN Rule). This amendment aims
The relationship between serological cholesterol levels, statin usage, and breast cancer (BC) mortality.
While a CRL is a rejection of the NDA in its current form, it’s not a total snubbing of MDMA-assisted therapy. The CRL, which is